Patents by Inventor Thomas Cannon

Thomas Cannon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12203064
    Abstract: A data collection hub and method wherein a controller is configured to receive data from a plurality of sensors sensing conditions related to the performance of operations on cells by at least one instrument. A database stores the data from the plurality of sensors and the controller is configured to compare data from the plurality of sensors for a past operation with the data for a more recent operation.
    Type: Grant
    Filed: June 18, 2023
    Date of Patent: January 21, 2025
    Assignee: Thrive Bioscience, Inc.
    Inventors: Howard Cannon, Thomas Forest Farb
  • Publication number: 20250019637
    Abstract: A data collection hub and method wherein a controller is configured to receive data from a plurality of sensors sensing conditions related to the performance of operations on cells by at least one instrument. A database stores the data from the plurality of sensors and the controller is configured to compare data from the plurality of sensors for a past operation with the data for a more recent operation.
    Type: Application
    Filed: September 24, 2024
    Publication date: January 16, 2025
    Inventors: Howard Cannon, Thomas Forest Farb
  • Publication number: 20240259461
    Abstract: The present disclosure describes a device, computer-readable medium, and method for an IPV4-to-IPv6 redirect to enable use of application function-specific user endpoint identifiers (AF-specific UEIds).
    Type: Application
    Filed: April 8, 2024
    Publication date: August 1, 2024
    Inventors: Shahram Mohajeri, Thomas Cannon
  • Patent number: 11956302
    Abstract: The present disclosure describes a device, computer-readable medium, and method for an IPv4-to-IPv6 redirect to enable use of application function-specific user endpoint identifiers (AF-specific UEIds).
    Type: Grant
    Filed: November 28, 2022
    Date of Patent: April 9, 2024
    Assignee: AT&T Intellectual Property I, L.P.
    Inventors: Shahram Mohajeri, Thomas Cannon
  • Publication number: 20230332095
    Abstract: The present invention provides automated devices for use in supporting various cell therapies and tissue engineering methods. The present invention provides an automated cell separation apparatus capable of separating cells from a tissue sample for use in cell therapies and/or tissue engineering. The cell separation apparatus can be used in combination with complementary devices such as cell collection device and/or a sodding apparatus to support various therapies. The automated apparatus includes media and tissue dissociating chemical reservoirs, filters, a cell separator and a perfusion flow loop through a graft chamber which supports a graft substrate or other endovascular device. The present invention further provides methods for using the tissue grafts and cell samples prepared by the devices described herein in a multitude of therapies including revascularization, regeneration and reconstruction of tissues and organs, as well as treatment and prevention of diseases.
    Type: Application
    Filed: January 18, 2023
    Publication date: October 19, 2023
    Applicant: TISSUE GENESIS INTERNATIONAL LLC
    Inventors: Gregory D. ARIFF, Thomas CANNON, Jennifer L. CASE, Christian L. HALLER, Paul KOSNIK, Charles P. LUDDY, Craig A. MAUCH, Erik VOSSMAN, Stuart K. WILLIAMS
  • Patent number: 11584912
    Abstract: The present invention provides automated devices for use in supporting various cell therapies and tissue engineering methods. The present invention provides an automated cell separation apparatus capable of separating cells from a tissue sample for use in cell therapies and/or tissue engineering. The cell separation apparatus can be used in combination with complementary devices such as cell collection device and/or a sodding apparatus to support various therapies. The automated apparatus includes media and tissue dissociating chemical reservoirs, filters, a cell separator and a perfusion flow loop through a graft chamber which supports a graft substrate or other endovascular device. The present invention further provides methods for using the tissue grafts and cell samples prepared by the devices described herein in a multitude of therapies including revascularization, regeneration and reconstruction of tissues and organs, as well as treatment and prevention of diseases.
    Type: Grant
    Filed: September 28, 2015
    Date of Patent: February 21, 2023
    Assignee: TISSUE GENESIS, INC
    Inventors: Gregory D. Ariff, Thomas Cannon, Jennifer L. Case, Christian L. Haller, Paul Kosnik, Charles P. Luddy, Craig A. Mauch, Erik Vossman, Stuart K. Williams
  • Publication number: 20220368971
    Abstract: Aspects of the subject disclosure may include, for example, a media server having a processing system including a processor; and a memory that stores executable instructions that, when executed by the processing system, facilitate sending a data stream to a display device. The data stream may include an identification thereof. Upon receiving the identification from a user, the media server associates the data stream with the user. The media server may send to the user, a listing of the media services to which the user has subscribed. Upon receiving, from the user, a selection of a selected media service, the media server streams the selected media service to the display device over the data stream. The data stream may be controlled with the user for as long as the media server detects the user in a vicinity of the display device. Other embodiments are disclosed.
    Type: Application
    Filed: July 20, 2022
    Publication date: November 17, 2022
    Applicant: AT&T Intellectual Property I, L.P.
    Inventors: Mark Easley, Vivek Mhatre, Thomas A. Cannon, JR.
  • Publication number: 20220294785
    Abstract: Concepts and technologies are disclosed for an identity vault service. According to one aspect disclosed herein, an identity vault service system can collect self-attested and operator-attested user information. The operator-attested user information can be associated with a user and a mobile telecommunications service provided to the user by a mobile network operator. The system can create a trusted digital identity of the user based upon the self-attested and operator-attested user information. The system can receive an identity access request from a third party. The request can be for access to at least a portion of the trusted digital identity for use by the third party in performance of an act. The system can send a consent request to a user device and can receive a consent response that indicates whether the user permits access to at least the portion of the trusted digital identity of the user.
    Type: Application
    Filed: May 26, 2022
    Publication date: September 15, 2022
    Applicant: AT&T Intellectual Property I, L.P.
    Inventors: Thomas A. Cannon, JR., William O'Hern, Aleksey Ivanov, Barbara Laing, Mark Easley
  • Patent number: 11425440
    Abstract: Aspects of the subject disclosure may include, for example, a media server having a processing system including a processor; and a memory that stores executable instructions that, when executed by the processing system, facilitate sending a datastream to a display device. The datastream may include an identification thereof. Upon receiving the identification from a user, the media server associates the datastream with the user. The media server may send to the user, a listing of the media services to which the user has subscribed. Upon receiving, from the user, a selection of a selected media service, the media server streams the selected media service to the display device over the datastream. The datastream may be controlled with the user for as long as the media server detects the user in a vicinity of the display device. Other embodiments are disclosed.
    Type: Grant
    Filed: July 21, 2020
    Date of Patent: August 23, 2022
    Assignee: AT&T Intellectual Property I, L.P.
    Inventors: Mark Easley, Vivek Mhatre, Thomas A. Cannon, Jr.
  • Patent number: 11349837
    Abstract: Concepts and technologies are disclosed for an identity vault service. According to one aspect disclosed herein, an identity vault service system can collect self-attested and operator-attested user information. The operator-attested user information can be associated with a user and a mobile telecommunications service provided to the user by a mobile network operator. The system can create a trusted digital identity of the user based upon the self-attested and operator-attested user information. The system can receive an identity access request from a third party. The request can be for access to at least a portion of the trusted digital identity for use by the third party in performance of an act. The system can send a consent request to a user device and can receive a consent response that indicates whether the user permits access to at least the portion of the trusted digital identity of the user.
    Type: Grant
    Filed: April 30, 2019
    Date of Patent: May 31, 2022
    Assignee: AT&T Intellectual Property I, L.P.
    Inventors: Thomas A. Cannon, Jr., William O'Hern, Aleksey Ivanov, Barbara Laing, Mark Easley
  • Publication number: 20200351534
    Abstract: Aspects of the subject disclosure may include, for example, a media server having a processing system including a processor; and a memory that stores executable instructions that, when executed by the processing system, facilitate sending a datastream to a display device. The datastream may include an identification thereof. Upon receiving the identification from a user, the media server associates the datastream with the user. The media server may send to the user, a listing of the media services to which the user has subscribed. Upon receiving, from the user, a selection of a selected media service, the media server streams the selected media service to the display device over the datastream. The datastream may be controlled with the user for as long as the media server detects the user in a vicinity of the display device. Other embodiments are disclosed.
    Type: Application
    Filed: July 21, 2020
    Publication date: November 5, 2020
    Applicant: AT&T Intellectual Property I, L.P.
    Inventors: Mark Easley, Vivek Mhatre, Thomas A. Cannon, JR.
  • Publication number: 20200351266
    Abstract: Concepts and technologies for are disclosed an identity vault service. According to one aspect disclosed herein, an identity vault service system can collect self-attested and operator-attested user information. The operator-attested user information can be associated with a user and a mobile telecommunications service provided to the user by a mobile network operator. The system can create a trusted digital identity of the user based upon the self-attested and operator-attested user information. The system can receive an identity access request from a third party. The request can be for access to at least a portion of the trusted digital identity for use by the third party in performance of an act. The system can send a consent request to a user device and can receive a consent response that indicates whether the user permits access to at least the portion of the trusted digital identity of the user.
    Type: Application
    Filed: April 30, 2019
    Publication date: November 5, 2020
    Applicant: AT&T Intellectual Property I, L.P.
    Inventors: Thomas A. Cannon, JR., William O'Hern, Aleksey Ivanov, Barbara Laing, Mark Easley
  • Patent number: 10757459
    Abstract: Aspects of the subject disclosure may include, for example, a media server having a processing system including a processor; and a memory that stores executable instructions that, when executed by the processing system, facilitate sending a datastream to a display device. The datastream may include an identification thereof. Upon receiving the identification from a user, the media server associates the datastream with the user. The media server may send to the user, a listing of the media services to which the user has subscribed. Upon receiving, from the user, a selection of a selected media service, the media server streams the selected media service to the display device over the datastream. The datastream may be controlled with the user for as long as the media server detects the user in a vicinity of the display device. Other embodiments are disclosed.
    Type: Grant
    Filed: December 10, 2018
    Date of Patent: August 25, 2020
    Assignee: AT&T Intellectual Property I, L.P.
    Inventors: Mark Easley, Vivek Mhatre, Thomas A. Cannon, Jr.
  • Publication number: 20200186857
    Abstract: Aspects of the subject disclosure may include, for example, a media server having a processing system including a processor; and a memory that stores executable instructions that, when executed by the processing system, facilitate sending a datastream to a display device. The datastream may include an identification thereof. Upon receiving the identification from a user, the media server associates the datastream with the user. The media server may send to the user, a listing of the media services to which the user has subscribed. Upon receiving, from the user, a selection of a selected media service, the media server streams the selected media service to the display device over the datastream. The datastream may be controlled with the user for as long as the media server detects the user in a vicinity of the display device. Other embodiments are disclosed.
    Type: Application
    Filed: December 10, 2018
    Publication date: June 11, 2020
    Applicant: AT&T Intellectual Property I, L.P.
    Inventors: Mark Easley, Vivek Mhatre, Thomas A. Cannon, JR.
  • Publication number: 20200024568
    Abstract: The present invention provides automated devices for use in supporting various cell therapies and tissue engineering methods. The present invention provides an automated cell separation apparatus capable of separating cells from a tissue sample for use in cell therapies and/or tissue engineering. The cell separation apparatus can be used in combination with complementary devices such as cell collection device and/or a sodding apparatus to support various therapies. The automated apparatus includes media and tissue dissociating chemical reservoirs, filters, a cell separator and a perfusion flow loop through a graft chamber which supports a graft substrate or other endovascular device. The present invention further provides methods for using the tissue grafts and cell samples prepared by the devices described herein in a multitude of therapies including revascularization, regeneration and reconstruction of tissues and organs, as well as treatment and prevention of diseases.
    Type: Application
    Filed: September 28, 2015
    Publication date: January 23, 2020
    Applicant: Tissue Genesis, Inc.
    Inventors: Gregory D. Ariff, Thomas Cannon, Jennifer L. Case, Christian L. Haller, Paul Kosnik, Charles P. Luddy, Craig A. Mauch, Erik Vossman, Stuart K. Williams
  • Patent number: 9683210
    Abstract: The present invention provides automated devices for use in supporting various cell therapies and tissue engineering methods. The present invention provides an automated cell separation apparatus capable of separating cells from a tissue sample for use in cell therapies and/or tissue engineering. The cell separation apparatus can be used in combination with complementary devices such as cell collection device and/or a sodding apparatus to support various therapies. The automated apparatus includes media and tissue dissociating chemical reservoirs, filters, a cell separator and a perfusion flow loop through a graft chamber which supports a graft substrate or other endovascular device. The present invention further provides methods for using the tissue grafts and cell samples prepared by the devices described herein in a multitude of therapies including revascularization, regeneration and reconstruction of tissues and organs, as well as treatment and prevention of diseases.
    Type: Grant
    Filed: September 28, 2015
    Date of Patent: June 20, 2017
    Assignee: Tissue Genesis, LLC
    Inventors: Gregory D. Ariff, Thomas Cannon, Jennifer L. Case, Christian L. Haller, Paul Kosnik, Charles P. Luddy, Craig A. Mauch, Erik Vossman, Stuart K. Williams
  • Publication number: 20160237396
    Abstract: The present invention provides automated devices for use in supporting various cell therapies and tissue engineering methods. The present invention provides an automated cell separation apparatus capable of separating cells from a tissue sample for use in cell therapies and/or tissue engineering. The cell separation apparatus can be used in combination with complementary devices such as cell collection device and/or a sodding apparatus to support various therapies. The automated apparatus includes media and tissue dissociating chemical reservoirs, filters, a cell separator and a perfusion flow loop through a graft chamber which supports a graft substrate or other endovascular device. The present invention further provides methods for using the tissue grafts and cell samples prepared by the devices described herein in a multitude of therapies including revascularization, regeneration and reconstruction of tissues and organs, as well as treatment and prevention of diseases.
    Type: Application
    Filed: September 28, 2015
    Publication date: August 18, 2016
    Applicant: Tissue Genesis, LLC
    Inventors: Gregory D. Ariff, Thomas Cannon, Jennifer L. Case, Christian L. Haller, Paul Kosnik, Charles P. Luddy, Craig A. Mauch, Erik Vossman, Stuart K. Williams
  • Patent number: 9144583
    Abstract: The present invention provides automated devices for use in supporting various cell therapies and tissue engineering methods. The present invention provides an automated cell separation apparatus capable of separating cells from a tissue sample for use in cell therapies and/or tissue engineering. The cell separation apparatus can be used in combination with complementary devices such as cell collection device and/or a sodding apparatus to support various therapies. The automated apparatus includes media and tissue dissociating chemical reservoirs, filters, a cell separator and a perfusion flow loop through a graft chamber which supports a graft substrate or other endovascular device. The present invention further provides methods for using the tissue grafts and cell samples prepared by the devices described herein in a multitude of therapies including revascularization, regeneration and reconstruction of tissues and organs, as well as treatment and prevention of diseases.
    Type: Grant
    Filed: April 23, 2007
    Date of Patent: September 29, 2015
    Assignee: Tissue Genesis, Inc.
    Inventors: Gregory D. Ariff, Thomas Cannon, Jennifer L. Case, Christian L. Haller, Paul Kosnik, Charles P. Luddy, Craig A. Mauch, Erik Vossman, Stuart K. Williams
  • Publication number: 20080032398
    Abstract: The present invention provides a feedback controlled bioculture platform for use as a precision cell biology research tool and for clinical cell growth and maintenance applications. The system provides individual closed-loop flowpath cartridges, with integrated, aseptic sampling and routing to collection vials or analysis systems. The system can operate in a standard laboratory or other incubator for provision of requisite gas and thermal environment. System cartridges are modular and can be operated independently or under a unified system controlling architecture, and provide for scale-up production of cell and cell products for research and clinical applications. Multiple replicates of the flowpath cartridges allow for individual, yet replicate cell culture growth and multiples of the experiment models that can be varied according to the experiment design, or modulated to desired cell development of cell culture end-points.
    Type: Application
    Filed: August 15, 2007
    Publication date: February 7, 2008
    Inventors: Thomas Cannon, Laura Cohn, Peter Quinn
  • Publication number: 20080014181
    Abstract: The present invention provides automated devices for use in supporting various cell therapies and tissue engineering methods. The present invention provides an automated cell separation apparatus capable of separating cells from a tissue sample for use in cell therapies and/or tissue engineering. The cell separation apparatus can be used in combination with complementary devices such as cell collection device and/or a sodding apparatus to support various therapies. The automated apparatus includes media and tissue dissociating chemical reservoirs, filters, a cell separator and a perfusion flow loop through a graft chamber which supports a graft substrate or other endovascular device. The present invention further provides methods for using the tissue grafts and cell samples prepared by the devices described herein in a multitude of therapies including revascularization, regeneration and reconstruction of tissues and organs, as well as treatment and prevention of diseases.
    Type: Application
    Filed: April 23, 2007
    Publication date: January 17, 2008
    Inventors: Gregory Ariff, Thomas Cannon, Jennifer Case, Christian Haller, Paul Kosnik, Charles Luddy, Craig Mauch, Erik Vossman, Stuart Williams